Cell-based cancer immunotherapy has revolutionized the treatment of hematological
malignancies. Specifically, autologous chimeric antigen receptor-engineered T (CAR-T) cell …

Induced pluripotent stem cells (iPSCs) derived from reprogrammed somatic cells are
emerging as one of the most versatile tools in biomedical research and pharmacological …

Tissues derived from induced pluripotent stem cells (iPSCs) are a promising source of cells
for building various regenerative medicine therapies; from simply transplanting cells to …

The discovery of induced pluripotent stem cells (iPSCs) has made an invaluable contribution
to the field of regenerative medicine, paving way for identifying the true potential of human …

The pace of research on human induced pluripotent stem (iPS) cells is frantic worldwide,
based on the enormous therapeutic potential of patient-specific pluripotent cells free of the …

The remarkable discovery of the derivation of induced pluripotent stem cells (iPSCs)
heralded the development of a new technological platform for therapeutic applications in …

Mesenchymal stem cells (MSCs) are adult stem cells with the capacity of self-renewal and
multilineage differentiation, and can be isolated from several adult tissues. However …

Summary iPSC technology provides unprecedented opportunities in biomedical research
and regenerative medicine. However, there remain a great deal to learn about iPSC safety …

Embryonic stem (ES) cells are widely used for different purposes, including gene targeting,
cell therapy, tissue repair, organ regeneration, and so on. However, studies and applications …

Human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) provide
an accessible, genetically tractable, and homogenous starting cell population to study …